Asset Details
Do you wish to reserve the book?
Hypothesis testing for an extended cox model with time‐varying coefficients
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hypothesis testing for an extended cox model with time‐varying coefficients
Do you wish to request the book?
Hypothesis testing for an extended cox model with time‐varying coefficients
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hypothesis testing for an extended cox model with time‐varying coefficients
2014
Overview
The log‐rank test has been widely used to test treatment effects under the Cox model for censored time‐to‐event outcomes, though it may lose power substantially when the model's proportional hazards assumption does not hold. In this article, we consider an extended Cox model that uses B‐splines or smoothing splines to model a time‐varying treatment effect and propose score test statistics for the treatment effect. Our proposed new tests combine statistical evidence from both the magnitude and the shape of the time‐varying hazard ratio function, and thus are omnibus and powerful against various types of alternatives. In addition, the new testing framework is applicable to any choice of spline basis functions, including B‐splines, and smoothing splines. Simulation studies confirm that the proposed tests performed well in finite samples and were frequently more powerful than conventional tests alone in many settings. The new methods were applied to the HIVNET 012 Study, a randomized clinical trial to assess the efficacy of single‐dose Nevirapine against mother‐to‐child HIV transmission conducted by the HIV Prevention Trial Network.
Publisher
Blackwell Publishers,Blackwell Publishing Ltd,International Biometric Society
Subject
/ biometry
/ Data Interpretation, Statistical
/ Female
/ HIV
/ HIV Infections - prevention & control
/ HIV/AIDS
/ Human immunodeficiency virus
/ Humans
/ Infectious Disease Transmission, Vertical - prevention & control
/ Infectious Disease Transmission, Vertical - statistics & numerical data
/ Nevirapine - administration & dosage
/ P values
/ Pregnancy Complications, Infectious - drug therapy
